Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Geschwindner

Showing results (41-50 of 50) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 50 results.
Communications Biology|December 18, 2020
Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibitionAmanda J Kennedy, Linda Sundström, Stefan Geschwindner, et al.
Scientific Reports|November 30, 2017
Molecular architecture of potassium chloride co-transporter KCC2Morgane Agez, Patrick Schultz, Igor Medina, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Journal of Medicinal Chemistry|November 8, 2007
Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiencyPhilip D Edwards, Jeffrey S Albert, Mark Sylvester, et al.
Nature Communications|October 28, 2020
A protein tertiary structure mimetic modulator of the Hippo signalling pathwayHélène Adihou, Ranganath Gopalakrishnan, Tim Förster, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 10, 2018
Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the TargetDean G Brown, Giles A Brown, Paolo Centrella, et al.
Journal of Molecular Biology|June 6, 2024
Robust Prediction of Relative Binding Energies for Protein-Protein Complex Mutations Using Free Energy Perturbation CalculationsJared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculationsJared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Nature|April 27, 2017
Structural insight into allosteric modulation of protease-activated receptor 2Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.
Circulation|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive PatientsRick B Vega, Gavin O'Mahony, April M Barbour, et al.
Pageof 5

Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Communications Biology|December 18, 2020
Protease-activated receptor-2 ligands reveal orthosteric and allosteric mechanisms of receptor inhibitionAmanda J Kennedy, Linda Sundström, Stefan Geschwindner, et al.
Scientific Reports|November 30, 2017
Molecular architecture of potassium chloride co-transporter KCC2Morgane Agez, Patrick Schultz, Igor Medina, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Journal of Medicinal Chemistry|November 8, 2007
Application of fragment-based lead generation to the discovery of novel, cyclic amidine beta-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiencyPhilip D Edwards, Jeffrey S Albert, Mark Sylvester, et al.
Nature Communications|October 28, 2020
A protein tertiary structure mimetic modulator of the Hippo signalling pathwayHélène Adihou, Ranganath Gopalakrishnan, Tim Förster, et al.
SLAS Discovery : Advancing Life Sciences R & D|January 10, 2018
Agonists and Antagonists of Protease-Activated Receptor 2 Discovered within a DNA-Encoded Chemical Library Using Mutational Stabilization of the TargetDean G Brown, Giles A Brown, Paolo Centrella, et al.
Journal of Molecular Biology|June 6, 2024
Robust Prediction of Relative Binding Energies for Protein-Protein Complex Mutations Using Free Energy Perturbation CalculationsJared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Biorxiv : the Preprint Server for Biology|May 7, 2024
Robust prediction of relative binding energies for protein-protein complex mutations using free energy perturbation calculationsJared M Sampson, Daniel A Cannon, Jianxin Duan, et al.
Nature|April 27, 2017
Structural insight into allosteric modulation of protease-activated receptor 2Robert K Y Cheng, Cédric Fiez-Vandal, Oliver Schlenker, et al.
Circulation|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naive PatientsRick B Vega, Gavin O'Mahony, April M Barbour, et al.
Pageof 5